AXTALIS
Ottergemsesteenweg Zuid 808/b300
9000 Gent
BE
AXTALIS
Foundation date
23/03/2020
Sector
#Professional Services and ConsultingSubsector
- #Professional Services - Drug development consulting
- #Professional Services - Market access
- #Professional Services - Market research
- #Professional Services - Reimbursement and pricing
AxTalis is a consulting company that focuses on market access, regulatory affairs and medical affairs to support strategies and early launch implementation for academia, pharmaceutical/Biotech and device companies. Our vision is to broaden the perspectives of patients to access drugs in a sustainable manner by collaborating closely with physicians, researchers, companies, payers and patients.
Market Access services include strategy development including EU/US Landscaping & pricing, GVD development, reimbursement files, Health economic modeling and outcome research. Flexible staffing allows us to provide temporary FTEs to companies on a time or project basis.
Services for Medical Affairs include medical writing, support for training development and implementation, stakeholder interaction & advisory boards, project development and implementation (early access, data generation/RWE, speaker programs, patient support programs). The creation and production of medical and promotional materials are supported by our ‘RIP’ activity and print service.
Our Regulatory Affairs services include healthcare policy and all aspects related to obtaining and maintaining registration of therapeutic solutions in the EU and US. We also have a dedicated team that supports companies with pharmacovigilance and medical information.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
Wednesday April 24th 2024
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
Jobs
More jobsMore info?
Ellen Telleir
Communication Coordinator